[en] Adult vampire bats (Desmodus rotundus) were vaccinated by intramuscular, scarification, oral, or aerosol routes (n=8 in each group) using a vaccinia-rabies glycoprotein recombinant virus. Sera were obtained before and 30 days after vaccination. All animals were then challenged intramuscularly with a lethal dose of rabies virus. Neutralizing antirabies antibodies were measured by rapid fluorescent focus inhibition test (RFFIT). Seroconversion was observed with each of the routes employed, but some aerosol and orally vaccinated animals failed to seroconvert. The highest antibody titers were observed in animals vaccinated by intramuscular and scarification routes. All animals vaccinated by intramuscular, scarification, and oral routes survived the viral challenge, but one of eight vampire bats receiving aerosol vaccination succumbed to the challenge. Of 31 surviving vaccinated and challenged animals, nine lacked detectable antirabies antibodies by RFFIT (five orally and four aerosol immunized animals). In contrast, nine of 10 non-vaccinated control bats succumbed to viral challenge. The surviving control bat had antiviral antibodies 90 days after viral challenge. These results suggest that the recombinant vaccine is an adequate and safe immunogen for bats by all routes tested.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Aguilar-Setien, A.; Hospital de Pediatrıa - Centro Me dico Nacional Siglo XXI > Unidad de Investigacion Medica en Inmunologıa
Campos, Y. L.; Hospital de Pediatrıa - Centro Me dico Nacional Siglo XXI > Unidad de Investigacion Medica en Inmunologıa
Cruz, E. T.; Hospital de Pediatrıa - Centro Me dico Nacional Siglo XXI > Unidad de Investigacion Medica en Inmunologıa
Kretschmer, R.; Hospital de Pediatrıa - Centro Me dico Nacional Siglo XXI > Unidad de Investigacion Medica en Inmunologıa
Brochier, B.; Institut Pasteur (Bruxelles)
Pastoret, Paul-Pierre ; Université de Liège - ULiège > Faculty of Veterinary Medicine > Immunology-Vaccinology
Language :
English
Title :
Vaccination of vampire bats using recombinant vaccinia-rabies virus
Publication date :
July 2002
Journal title :
Journal of Wildlife Diseases
ISSN :
0090-3558
Publisher :
Wildlife Disease Association, United States - Kansas
ACHA, P. N., AND P. V. ARAMBULO. 1985. Rabies in the tropics-history and current status. In Rabies in the tropics, E. Kuwert, C. Merieux, H. Koprowski and K. Bogel, (eds). Springer-Verlag, New York, New York, pp. 780-786.
_, AND A. MALAGA ALBA. 1988. Economic losses due to Desmodus rotundus. In Natural history of vampire bats, M. A. Greenhall and U. Schimidt (eds.). CRC Press Inc., Boca Raton, Florida, pp. 208-213.
AGUILAR-SETIÉN, A., B. BROCHIER, N. TORDO, O. DE PAZ, P. DESMETTRE, D. PÉHARPRÉ, AND P. P. PASTORET. 1998. Experimental rabies infection and rabies vaccination in vampire bats (Desmodus rotundus). Vaccine 16: 1122-1126.
ANDERSON, R. M. 1982. The population dynamics of infectious disease: Theory and applications. Chapman and Hall, London, England, pp. 241-261.
ARTOIS, M., C. GUITTRE, I. THOMAS, H. LEBLOIS, B. BHOCHIER, AND J. BARRAT. 1992. Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies. A comparison. Vaccine 10: 524-528.
BAER, G. M., AND J. S. SMITH. 1991. Rabies in nonhematophagous bats. In The natural history of rabies, 2nd Edition, G. M. Baer (ed.). CRC Press Inc., Boca Raton, Florida, pp. 341-366.
BLANCOU, J., M. F. A. AUBERT, L. ANDRAL, AND M. ARTOIS. 1979. Rage expérimentale du renard roux (Vulpes vulpes): I. Sensibilité selon la voie d'infection et la dose infectante. Revue de Médecine Vétérinaire 130: 1001-1015.
BOGEL, K., H. MOEGLE, F. STECK, W. KROCZA, AND L. ANDRAL. 1981. Assessment of fox control in areas of wildlife rabies. Bulletin of the World Health Organization 59: 269-279.
BOULANGER, D., B. BROCHIER, A. CROUCH, M. BENNETT, R. M. GASKELL, D. BAXBY, AND P. P. PASTORET. 1995. Comparison of the susceptibility of the red fox (Vulpes vulpes) to a vaccinia-rabies recombinant virus and to cowpox virus. Vaccine 13: 215-220.
BROCHIER, B., J. BLANCOU, I. THOMAS, B. LANGUET, M. ARTOIS, M. P. KIENY, J. P. LECOCQ, F. COSTY, P. DESMETTRE, G. CHAPPUIS, AND P. P. PASTORET. 1989. Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies. Innocuity to several non-target bait consuming species. Journal of Wildlife Diseases 25: 540-547.
_, M. P. KIENY, F. COSTY, P. COPPENS, B. BAUDUIN, J. P. LECOCQ, B. LANGUET, G. CHAPPUIS, P. DESMETTRE, K. AFIADEMANYO, R. LIBOIS, AND P. P. PASTORET. 1991. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 354: 520-522.
BURNS, K. F., AND C. FARINACCI. 1955. Rabies in nonsanguivorous bats of Texas. Journal of Infectious Disease 97: 211-218.
COMMISSION OF LIFE SCIENCES. 1996. Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources, National Research Council, National Academy Press, Washington D.C., 146 pp.
CUEVAS ROMERO, S., V. G. COLMENARES, D. BATALLA CAMPERO, AND E. HERNANDEZ BAUMGARTEN. 1989. Selección de un virus rábico de origen vampiro para utilizarse como cepa de desafío en bovinos. Veterinaria México 20: 117-122.
DAWSON-SAUNDERS, B., AND R. G. TRAPP. 1994. Basic and clinical biostatistics, 2nd Edition, Appleton and Langue, Norwalk, Connecticut, 344 pp.
DEAN, D. J., AND M. M. ABELSETH. 1973. The fluorescent antibody test. In Laboratory techniques in rabies, M. M. Kaplan and H. Koprowski (eds.). World Health Organization, Geneva, Switzerland, pp. 73-80.
FLORES CRESPO, R. 1991. Rabia en humanos transmitida por murciélagos vampiros en paises de América. Técnica Pecuaria en México 29: 25-33.
HAUPT, W. 1999. Rabies - risk of exposure and current trends in prevention of human cases. Vaccine 17: 1742-1749.
KIENY, M. P., R. LATHE, R. DRILLEN, D. SPEHNER, S. SKORY, O. SCHMITT, T. WIKTOR, H. KOPROWSKI, AND J. P. LECOCQ. 1984. Expression of rabies virus glycoprotein from a recombinant vaccinia-virus. Nature 312: 163-166.
LORD, R. 1988. Control of vampire bats. In Natural history of vampire bats, M. A. Greenhall and U. Schimidt (eds.). CRC Press Inc., Boca Raton, Florida, pp. 215-225.
MCCOLL, K. A., N. TORDO, AND A. AGUILAR-SETIÉN. 2000. Bat lyssavirus infections. Revue Scientifique et Technique 19: 177-196.
MEDZHITOV, R., AND C. JANEWAY, JR. 2000. Advances in immunology: Innate immunity. The New England Journal of Medicine 343: 338-344.
MORENO, J. A., AND G. M. BAER. 1980. Experimental rabies in the vampire bat. American Journal of Tropical Medicine 29: 254-259.
MORIMOTO, K., M. PATEL, S. CORISDEO, D. C. HOOPER, Z. FANG FU, C. E. RUPPRECHT, H. KOPROWSKI, AND B. DIETZSCHOLD. 1996. Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proceedings of the National Academy of Sciences 93: 5653-5658.
NAVARRETE NAVARRO, S., A. AGUILAR-SETIÉN, C. AVILA FIGUEROA, F. HERNANDEZ SIERRA, AND J. I. SANTOS PRECIADO. 1999. Improved serological response to human diploid cell rabies vaccine when given simultaneously with antirrabies hyperimmune globulin. Archives of Medical Research 30: 332-337.
NOAH, D. L., C. H. L. DRENZEK, J. S. SMITH, J. W. KREBS, L. ORCIARI, J. SHADDOCK, D. SANDERLIN, S. WHITEFIELD, M. FEKADU, J. G. OLSON, C. E. RUPPRECHT, AND J. E. CHILDS. 1998. Epidemiology of human rabies in the United States, 1980 to 1996. Annals of Internal Medicine 128: 922-930.
PAN-AMERICAN HEALTH ORGANIZATION. 1991. Informe final: Reunión de consulta sobre la atención a personas expuestas a la rabia transmitida por vampiros. Organización Panamericana de la Salud, Washington D.C., 13 pp.
PASTORET, P. P., B. BROCHIER, J. BLANCOU, M. ARTOIS, M. F. A. AUBERT, M. P. KIENY, J. P. LECOCQ, B. LANGUET, G. CHAPPUIS, AND P. DESMETTRE. 1992. Development and deliberate release of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies. In Recombinant poxviruses, G. L. Smith and M. Brinns (eds.). CRC Press Inc., Boca Raton, Florida, pp. 163-185.
_, D. BOULANGER, AND B. BROCHIER. 1995. Field trials of a recombinant rabies vaccine. Parasitology 110: S37-S42.
PINCALI, D., AND E. PAOLETTI. 1982. Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase gene from HSV into the DNA of infectious vaccinia virus. Proceedings of the National Academy of Sciences USA 79: 4927-4936.
PRABHAKAR, B. S., AND N. NATHANSON. 1981. Acute rabies death mediated by antibody. Nature (London) 290: 590-592.
RUPPRECHT, C. E., A. N. HAMIR, D. H. JHONSTON, AND H. KOPROWSKI. 1988. Oral efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Reviews of Infectious Diseases 10 (S4): S803-S808.
_, L. BLASS, K. SMITH, L. A. ORCIARI, M. NIEZGODA, S. G. WHITFIELD, R. V. GIBBONS, M. GUERRA, AND C. A. HANLON. 2001. Human infection due to recombinant vaccinia-rabies glycoprotein virus. The New England Journal of Medicine 345: 582-586.
SMITH, J. S., P. A. YAGER, AND C. M. BAER. 1973. A rapid tissue culture test for determining rabies neutralizing antibodies. In Laboratory techniques in rabies, 3rd Edition, M. M. Kaplan and II. Koprowski (eds.). World Health Organization, Geneva, Switzerland, pp. 354-360.
SOULEBOT, J. P., A. BRUN, G. CHAPPUIS, F. GUILLEMIN, AND G. TIXIER. 1982. Rabies virus pathogenicity and challenge. Influence of the method of preparation, the route of inoculation, and the species. Comparison of the characteristics of the modified fixed and wild strains. Comparative Immunological and Microbiological Infectious Diseases 5: 71-78.
TOMA, B., AND L. ANDRAL. 1977. Epidemiology of fox rabies. Advances in Virus Research 21: 1-15.
